BI-SILICA During Transcatheter Aortic Valve Replacement for Noncalcific Aortic Insufficiency: Initial Human Experience

Norihiko Kamioka; Robert J. Lederman; Jaffar M. Khan; Stamatios Lerakis; Altayyeb Yousef; Patrick T. Gleason; Kendra J. Grubb; Robert A. Guyton; Bradley Leshnower; Peter C. Block; Adam B. Greenbaum; Vasilis C. Babaliaros

doi:10.1016/j.jcin.2018.08.015

BI-SILICA During Transcatheter Aortic Valve Replacement for Noncalcific Aortic Insufficiency: Initial Human Experience

Norihiko Kamioka, Robert J. Lederman, Jaffar M. Khan, Stamatios Lerakis, Altayyeb Yousef, Patrick T. Gleason, Kendra J. Grubb, Robert A. Guyton, Bradley Leshnower, Peter C. Block, Adam B. Greenbaum, Vasilis C. Babaliaros

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	2237-2239
Number of pages	3
Journal	JACC: Cardiovascular Interventions
Volume	11
Issue number	21
DOIs	https://doi.org/10.1016/j.jcin.2018.08.015
State	Published - 12 Nov 2018

Access to Document

10.1016/j.jcin.2018.08.015

Cite this

Kamioka, N., Lederman, R. J., Khan, J. M., Lerakis, S., Yousef, A., Gleason, P. T., Grubb, K. J., Guyton, R. A., Leshnower, B., Block, P. C., Greenbaum, A. B., & Babaliaros, V. C. (2018). BI-SILICA During Transcatheter Aortic Valve Replacement for Noncalcific Aortic Insufficiency: Initial Human Experience. JACC: Cardiovascular Interventions, 11(21), 2237-2239. https://doi.org/10.1016/j.jcin.2018.08.015

@article{65a6f050a54b4c53a8483c915c0f7b9c,

title = "BI-SILICA During Transcatheter Aortic Valve Replacement for Noncalcific Aortic Insufficiency: Initial Human Experience",

author = "Norihiko Kamioka and Lederman, \{Robert J.\} and Khan, \{Jaffar M.\} and Stamatios Lerakis and Altayyeb Yousef and Gleason, \{Patrick T.\} and Grubb, \{Kendra J.\} and Guyton, \{Robert A.\} and Bradley Leshnower and Block, \{Peter C.\} and Greenbaum, \{Adam B.\} and Babaliaros, \{Vasilis C.\}",

note = "Funding Information: Please note: This work was supported using intramural funds, Emory Structural Heart and Valve Center, and by National Institutes of Health grant Z01-HL006040-7. Dr. Lerakis has been a consultant for Edwards Lifesciences and Abbott Vascular. Dr. Grubb has been a speaker, proctor, and advisory board member for Medtronic and Boston Scientific. Dr. Guyton has served as the national principal investigator on the Edwards Lifesciences TMVR early feasibility trial. Dr. Leshnower has served on the speakers bureau for Medtronic. Dr. Greenbaum has been a proctor for Edwards Lifesciences and Abbott Vascular. Dr. Babaliaros has been a consultant for and received research grant support from Abbott Vascular and Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2018",

month = nov,

day = "12",

doi = "10.1016/j.jcin.2018.08.015",

language = "English",

volume = "11",

pages = "2237--2239",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "21",

}

Kamioka, N, Lederman, RJ, Khan, JM, Lerakis, S, Yousef, A, Gleason, PT, Grubb, KJ, Guyton, RA, Leshnower, B, Block, PC, Greenbaum, AB & Babaliaros, VC 2018, 'BI-SILICA During Transcatheter Aortic Valve Replacement for Noncalcific Aortic Insufficiency: Initial Human Experience', JACC: Cardiovascular Interventions, vol. 11, no. 21, pp. 2237-2239. https://doi.org/10.1016/j.jcin.2018.08.015

TY - JOUR

T1 - BI-SILICA During Transcatheter Aortic Valve Replacement for Noncalcific Aortic Insufficiency

T2 - Initial Human Experience

AU - Kamioka, Norihiko

AU - Lederman, Robert J.

AU - Khan, Jaffar M.

AU - Lerakis, Stamatios

AU - Yousef, Altayyeb

AU - Gleason, Patrick T.

AU - Grubb, Kendra J.

AU - Guyton, Robert A.

AU - Leshnower, Bradley

AU - Block, Peter C.

AU - Greenbaum, Adam B.

AU - Babaliaros, Vasilis C.

N1 - Funding Information: Please note: This work was supported using intramural funds, Emory Structural Heart and Valve Center, and by National Institutes of Health grant Z01-HL006040-7. Dr. Lerakis has been a consultant for Edwards Lifesciences and Abbott Vascular. Dr. Grubb has been a speaker, proctor, and advisory board member for Medtronic and Boston Scientific. Dr. Guyton has served as the national principal investigator on the Edwards Lifesciences TMVR early feasibility trial. Dr. Leshnower has served on the speakers bureau for Medtronic. Dr. Greenbaum has been a proctor for Edwards Lifesciences and Abbott Vascular. Dr. Babaliaros has been a consultant for and received research grant support from Abbott Vascular and Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2018/11/12

Y1 - 2018/11/12

UR - https://www.scopus.com/pages/publications/85055693549

U2 - 10.1016/j.jcin.2018.08.015

DO - 10.1016/j.jcin.2018.08.015

M3 - Letter

C2 - 30409286

AN - SCOPUS:85055693549

SN - 1936-8798

VL - 11

SP - 2237

EP - 2239

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 21

ER -